[ACRS] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[ACRS] Aclaris Therapeutics, Inc.
Announcement Date
08-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- 20.69%
YoY- -51.12%
Quarter Report
ACRS's Result
ACRS's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 17,570 9,282 1,869 2,528 7,753 19,018 1,528 407.18%
PBT -1,858 -29,261 -29,569 -28,160 -27,635 -19,952 -20,532 -79.75%
Tax -367 -219 -1,500 -1,758 5,656 1,278 -3,862 -79.08%
NP -1,491 -29,261 -29,569 -26,402 -33,291 -21,230 -16,670 -79.91%
Tax Rate - - - - - - - -
Total Cost 19,061 38,543 31,438 28,930 41,044 40,248 18,198 3.12%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -8.49 -315.24 -1,582.08 -1,044.38 -429.40 -111.63 -1,090.97 -96.03%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.02 -0.41 -0.42 -0.39 -0.50 -0.32 -0.25 -81.34%
EPS Diluted -0.02 -0.41 -0.42 -0.39 -0.50 -0.32 -0.25 -81.34%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.